MedCity News

NOVEMBER 8, 2024

The FDA has proposed removing oral phenylephrine from its guidelines for over-the-counter drugs due to inefficacy as a decongestant. Use of this ingredient in cold and allergy medicines grew after a federal law required that pseudoephedrine-containing products be kept behind pharmacy counters. The post FDA Takes Step Toward Removal of Ineffective Decongestants From the Market appeared first on MedCity News.

FDA 306

FDA Marketing Medicine Biopharma 306

Fierce Pharma

NOVEMBER 8, 2024

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and improper collection of patient data. | AstraZeneca confirmed its China president has been detained by Chinese authorities. Pfizer plans to invest $1 billion in China in the next five years. Sun Pharma's JAK inhibitor Leqselvi was slapped with an injunction in a lawsuit with Incyte.

Pharma 258

Pharma Patients 258

MedCity News

NOVEMBER 8, 2024

Many companies are entering the digital youth mental health space, but it’s important to know which ones are effective, according to a panel of investors at the Behavioral Health Tech conference. The post Measuring Impact in Digital Youth Mental Health: What Investors Look For appeared first on MedCity News.

306

306

Fierce Pharma

NOVEMBER 8, 2024

After a positive phase 3 trial, Johnson & Johnson hopes its Darzalex could become the first treatment option for patients with smoldering multiple myeloma, an early-stage form of the blood diso | After a positive phase 3 trial, Johnson & Johnson hopes its Darzalex could become the first treatment option for patients with smoldering multiple myeloma, an early-stage form of the blood disorder.

FDA 232

FDA Patients 232

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

MedCity News

NOVEMBER 8, 2024

While startups in highly regulated industries like healthcare and finance are almost certain to face heightened scrutiny, there are controllable factors that can offset these challenges. The post The Startup Economy is Turbulent. Here’s How Founders Can Recognize and Avoid Common Pitfalls appeared first on MedCity News.

Healthcare 311

Healthcare Healthcare 311

PharmaVoice

NOVEMBER 8, 2024

Past comments hint at the changes Robert F. Kennedy Jr. could make across the various sectors of healthcare.

Pharma 279

Pharma Healthcare Healthcare 279

Fierce Pharma

NOVEMBER 8, 2024

With Indivior’s stock price in freefall over the past year, one of the company’s top investors is taking leadership to task, accusing the firm behind the opioid addiction treatment Sublocade of “ig | Investment fund Oaktree Capital Management has called for a shakeup of Indivior’s board of directors, referring to the more than 50% stock price drop Indivior has suffered in 2024 as “unacceptable.

Management 150

Management 150

Impetus Digital

NOVEMBER 8, 2024

A version of this article was previously published in the Journal of mHealth. The landscape of publication planning is constantly evolving with the rise of novel digital tools, artificial intelligence, and virtual collaboration platforms. As a result, traditional barriers to effective and efficient publication planning and development are being broken down, while new challenges related to compliance, data security, and global collaboration in the virtual setting have emerged.

Management 85

Management Healthcare Provider Medical Pharma 85

Fierce Pharma

NOVEMBER 8, 2024

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, WuXi AppTec and | The company opted not to renew its membership for 2025 following an annual review of its trade group associations, a spokesperson said.

249

249

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

European Pharmaceutical Review

NOVEMBER 8, 2024

A study has reported a novel microbiology approach using TPX polymer film to culture bacteria in a liquid static culture. One key challenge of culturing in microbiology is that since oxygen does not dissolve easily in the liquid medium typically used during this process, the medium must be vigorously aerated, usually by shaking, which causes shear stress of the microorganisms, the Japanese researchers explained.

Pharmaceutical 59

Pharmaceutical 59

Fierce Pharma

NOVEMBER 8, 2024

Common oral medicines that have been used for decades as decongestants such as Sudafed, NyQuil and Benadryl may soon be cleared from shelves as the FDA has

FDA 226

FDA Medicine 226

pharmaphorum

NOVEMBER 8, 2024

AstraZeneca has revealed that its top executive in China, Leon Wang, has been detained by Chinese authorities

137

137

Fierce Pharma

NOVEMBER 8, 2024

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that AstraZeneca and Amgen's Tezspire provided a statistically significant and clinically meaningful reduction in polyp size and nasal congestion in patients with severe chronic rhinosinusitis with nasal polyps.

Patients 202

Patients 202

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

pharmaphorum

NOVEMBER 8, 2024

Eisai has scaled down its sales expectations for Alzheimer's disease drug Leqembi after sluggish sales growth in the first half of the current fiscal year.

Sales 124

Sales 124

Fierce Pharma

NOVEMBER 8, 2024

With biomanufacturing often a limiting factor for drug developers, Canada’s Future Fields is heralding its bug-based approach to protein production as a potential salve. | With biomanufacturing often a limiting factor for drug developers, Canada’s Future Fields is heralding its bug-based approach to protein production as a potential salve. Now, after several years spent validating its manufacturing platform, the company is expanding in a big way with the debut of a new service line and factory i

Manufacturing 182

Manufacturing 182

pharmaphorum

NOVEMBER 8, 2024

Daiichi Sankyo signs a $300m deal with Alteogen to develop a subcutaneous version of anti-HER2 cancer drug Enhertu.

118

118

Pharmaceutical Technology

NOVEMBER 8, 2024

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including Ozempic.

Food 105

Food Sales 105

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

pharmaphorum

NOVEMBER 8, 2024

Wales has extended a scheme to harness the power of genomics to improve cancer care and prevention via an alliance with gene-sequencing giant Illumina.

105

105

Pharmaceutical Technology

NOVEMBER 8, 2024

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its primary endpoint.

Patients 105

Patients 105

pharmaphorum

NOVEMBER 8, 2024

The UK is squandering the vast resource of NHS patient data because too many obstacles are being placed in front of researchers trying to tap into it – holding back medical advances. That is the conclusion of the much-anticipated Sudlow Review – carried out by Prof Cathie Sudlow, chief scientist of Health Data Research (HDR) UK – which found that accessing patient data can take months or even years, hampering research into areas like dementia, cancer and heart disease.

Medical 85

Medical Patients 85

Pharmaceutical Technology

NOVEMBER 8, 2024

Analysis of future trends highlights that the cold chain logistics sector is at a critical juncture, with tech advancements driving change.

Pharma 98

Pharma 98

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmacy Times

NOVEMBER 8, 2024

Though both vaccines remain effective at preventing severe illness, Moderna’s mRNA-1273.222 vaccine was found to be significantly more effective among adults with underlying medical conditions.

Medical 52

Medical Patients 52

Pharmaceutical Technology

NOVEMBER 8, 2024

Leqembi is approved for Alzheimer’s patients in multiple territories, but questions remain over its cost-effectiveness.

Marketing 96

Marketing Patients 96

Pharmacy Times

NOVEMBER 8, 2024

The drug is being investigated for its potential to reduce fibrosis associated with muscular dystrophy that can cause scarring of the heart tissue.

FDA 52

FDA 52

Pharmaceutical Technology

NOVEMBER 8, 2024

Mustang Bio has received orphan drug designation from the US Food and Drug Administration (FDA) for MB-108, a herpes simplex virus type 1 oncolytic virus and a component of MB-109, designed to treat malignant glioma.

Food and Drug Administration 59

Food and Drug Administration FDA Food 59

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Close-Up CRM

NOVEMBER 8, 2024

As the pharmaceutical sales landscape continues to evolve, the dynamic between field sales teams and commercial operations is a linchpin of success. Field sales representatives are the critical link between healthcare professionals (HCPs) and pharmaceutical companies, delivering key messages, gathering valuable insights, and driving product adoption.

Sales 52

Sales CRM Pharma Pharmaceutical 52

PharmaTech

NOVEMBER 8, 2024

Pharmaceutical training programs are enhanced by integrating ICH quality risk management considerations.

Training 52

Training Management Pharmaceutical 52

Close-Up CRM

NOVEMBER 8, 2024

As the world of Customer Relationship Management continues to change at breakneck speed, analytics, and business intelligence (BI) have become critical components for organizations seeking to gain a competitive edge. As we move into 2025, the integration of advanced analytics within CRM software and systems is not just a luxuryit is a necessity. This article explores the latest trends and best practices in CRM analytics, drawing insights from recent industry analyses and expert observations.

CRM 52

CRM Customer Relationship Management Government Relationship management 52